万古霉素预浸泡移植物在大鼠前交叉韧带重建模型中不损害移植物-骨愈合
研究在大鼠前交叉韧带重建(ACLR)模型中,将移植物浸泡于5 mg/mL万古霉素溶液或生理盐水,评估对移植物-骨愈合的影响。结果显示万古霉素组在0时点显著减少移植物细菌污染(P = .02),而4周和12周生物力学、micro-CT及组织学评价两组间均无显著差异。结论认为万古霉素预浸泡在大鼠ACLR模型中未显示对短期和中期移植物-骨愈合的不良影响。
要点
- 万古霉素预浸泡显著减少0时点移植物细菌污染(P = .02)。
- 4周和12周最大失效载荷两组间均无显著差异(P = .95和P = .35)。
- micro-CT骨隧道体积及组织学半定量评价各时间点两组间无显著差异。
核心结论
- 在大鼠ACLR模型中,万古霉素预浸泡移植物在短期和中期生物力学、影像学及组织学检查中未显示明显不良影响。
研究设计与样本
- 对照实验室研究,使用9只Wistar大鼠的趾长屈肌腱随机分配至生理盐水(NS)组或万古霉素溶液(VS)组。
- 65只雄性Wistar大鼠右膝行ACLR,移植物同样处理,术后4周和12周进行生物力学、micro-CT和组织学评价。
主要发现
- VS组0时点移植物污染显著减少(P = .02)。
- 4周最大失效载荷NS组13.7 ± 8.2 N vs VS组11.6 ± 4.8 N(P = .95);12周NS组23.2 ± 13.2 N vs VS组30.4 ± 18.0 N(P = .35)。
- 4周骨隧道体积NS组3.76 ± 0.48 mm3 vs VS组4.40 ± 0.58 mm3(P = .41);12周NS组3.51 ± 0.38 mm3 vs VS组3.67 ± 0.35 mm3(P = .54)。
- 组织学半定量检查各时间点两组间无明确差异。
关键数值与推荐
- NS组移植物浸泡于无菌生理盐水30分钟,VS组浸泡于5 mg/mL万古霉素溶液。
- 移植物在Fluidised Thioglycollate Broth中孵育2周以确认0时点细菌污染。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The vancomycin presoaking technique (wherein grafts are treated with a vancomycin solution [VS] for anterior cruciate ligament reconstruction [ACLR]) reduces the infection rate after ACLR. However, the effects of this technique on graft-bone healing have not been fully elucidated. PURPOSE: To investigate the effects of vancomycin presoaking on graft-bone healing in a rat ACLR model. STUDY DESIGN: Controlled laboratory study. METHODS: Long flexor digitorum longus tendons were obtained from 9 Wistar rats, and each was randomly allocated to the normal saline (NS) or VS groups. The grafts were immersed in sterile saline for 30 minutes in the NS group and in a 5-mg/mL VS in the VS group. The presence of time-zero graft bacterial contamination was confirmed, and the grafts were incubated in Fluidised Thioglycollate Broth for 2 weeks. ACLR was performed on the right knees of 65 male Wistar rats using the flexor digitorum longus tendons. Each graft was similarly treated. Biomechanical testing, micro-computed tomography, and histological evaluations were performed 4 and 12 weeks postoperatively. RESULTS: The VS group showed significantly reduced graft contamination at time zero (P = .02). The mean maximum loads to failure were 13.7 ± 8.2 N and 11.6 ± 4.8 N in the NS and VS groups, respectively, at 4 weeks (P = .95); and 23.2 ± 13.2 N and 30.4 ± 18.0 N in the NS and VS groups, respectively, at 12 weeks (P = .35). Regarding micro-computed tomography, the mean bone tunnel volumes were 3.76 ± 0.48 mm3 and 4.40 ± 0.58 mm3 in the NS and VS groups, respectively, at 4 weeks (P = .41); and 3.51 ± 0.38 mm3 and 3.67 ± 0.35 mm3 in the NS and VS groups, respectively, at 12 weeks (P = .54). Histological semiquantitative examination revealed no clear between-group differences at any time point. CONCLUSION: Presoaking grafts in vancomycin in a rat ACLR model demonstrated no discernible adverse effects on short- and midterm biomechanical, radiological, and histological investigations. CLINICAL RELEVANCE: The findings provide guidance for surgeons when considering this technique.
引用
- Yoshida R, Koga H, Matsuda J, et al. Presoaking Grafts in Vancomycin Does Not Impair Graft-Bone Healing in a Rat Anterior Cruciate Ligament Reconstruction Model. Am J Sports Med. 2024. PMID: 38721771. doi:10.1177/03635465241247843
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。